-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Silvia Escribano Serrat, MD1*, Paola Charry, MD2*, Luis Gerardo Rodríguez-Lobato, MD, PhD2*, Ana Belén Moreno-Castaño, MD, PhD Student3*, María Suárez-Lledó, MD2*, Nuria Martínez-Cibrian, MD2*, María Teresa Solano2*, Jordi Arcarons2*, Meritxell Nomdedeu, MD2*, Joan Cid4*, Miquel Lozano, PhD2*, Alexandra Pedraza2*, Laura Rosiñol, MD, PhD2*, Jordi Esteve, MD, PhD2, Álvaro Urbano-Ispizua, MD, PhD2, Marta Palomo, PhD2*, Francesc Fernández-Avilés, MD2*, Maria Carmen Martinez Munoz, PhD2*, Maribel Diaz-Ricart, PhD3*, Enric Carreras, MD, PhD5*, Montserrat Rovira, MD, PhD2* and María Queralt Salas, MD6*

1Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, IdiSSC, Madrid, Spain
2Hematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
3Hematopathology, Pathology Department, CDB, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
4Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, ICMHO, IDIBAPS, Hospital Clínic, Barcelona, Spain
5Fundació i Institut de Recerca Josep Carreras contra la leucèmia (Campus Clínic), Barcelona, Spain
6Hematopoietic Transplantation Unit and Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain

Erik Thiele Orberg, MD, PhD1*, Elisabeth Meedt, MD2*, Andreas Hiergeist3*, Jinling Xue4*, Paul Heinrich5*, Sakhila Ghimire, BSc, MSc, PhD6*, Melanie Tiefgraber7*, Sophia Göldel7*, Tina Eismann7*, Alix Schwarz8*, Sebastian Jarosch9*, Katja Steiger10*, Karin Kleigrewe11*, Julius Clemens Fischer12*, Klaus-Peter Janssen13*, Michael Quante14*, Simon Heidegger15*, Peter Herhaus, MD16*, Mareike Verbeek17*, Jürgen Ruland18*, Christian Schulz19*, Daniela Weber, MD20*, Matthias Edinger, MD, PhD21*, Daniel Wolff, MD21*, Dirk Busch22*, Wolfgang Herr, MD21, Florian Bassermann23*, Li Deng4*, Andre Gessner3*, Ernst Holler, MD, PhD24 and Hendrik Poeck, MD25

1Department of Hematology and Oncology, University Hospital Rechts der Isar of the Technical University of Munich, Munich, Germany
2Blood and Marrow Transplantation Program, University Hospital Regensburg, Regensburg, DEU
3Institute of Clinical Microbiology and Hygiene, Regensburg, DEU
4Helmholtz Zentrum München, Munich, Germany
5University Hospital Regensburg, Regensburg, Germany
6University Hospital Regensburg, Regensburg, Bavaria, DEU
7University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany
8University Hospital Rechts der Isar of the Technical University of Munich, Munich, Germany
9Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany
10Institute of Pathology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
11Bavarian Center for Biomolecular Mass Spectrometry, Freising, Germany
12Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
13Department of Surgery, Technical University of Munich (TUM), School of Medicine, Klinikum rechts der Isar TUM, Munich, Germany
14University Hospital Freiburg, Freiburg, Germany
15Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany
16Internal Medicine III, School of Medicine, Klinikum rechts der Isar, Technische Universität München, München, Germany
17Technische Universitaet Muenchen, Munich, DEU
18Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany
19LMU University of Munich, Munich, DEU
20Internal Medicine III, University Clinic Regensburg, Regensburg, Germany
21Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
22Medical Microbiology, Immunology and Hygiene, Munich, DEU
23Department of Internal Medicine III, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
24Department of Internal Medicine III, Univeristy Hospital Regensburg, Regensburg, Germany
25Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Bavaria, Germany

Vladimir I. Vorobyev, MD1, Anton Yu. Subora, MD2*, Yulia A. Oleinik, MD3*, Lev S. Butaev, MD4*, Vera A. Zherebtsova, MD, PhD2*, Darya G. Kisilichina, PhD2*, Margarita A. Ulyanova, MD2*, Evdokiya S. Urnova, MD2*, Alena M. Sukhareva, MD2* and Matvei P. Bulusov, MD2*

1Bone Marrow Transplant, Botkin Hospital, Moscow, Russia
2Bone Marrow Transplant, Botkin Hospital, Moscow, Russian Federation
3Botkin Hospital, Moscow, Russian Federation
4Bone Marrow transplant, Botkin Hospital, Moscow, Russian Federation

Huiying Qiu1*, Jiahua Niu1*, Xi Sun1*, Huajun Li2*, Juan Yang1*, Chongmei Huang1*, Yu CAI1*, Kun Zhou1*, Yin Tong1*, Liping Wan1* and Xianmin Song, phd1*

1Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, shanghai, China
2Clinical Research & Development, Jiangsu Hengrui pharmaceuticals Co., Ltd., shanghai, China

Maria Queralt Salas, MD1,2*, Abel Santos Carreira, MD3*, Eshetu G. Atenafu, M.Sc., P.Stat4*, Tommy Alfaro Moya3*, Arjun D. Law, MD5*, Wilson Lam, MD6*, Ivan Pasic7*, Carol Chen6*, Dennis Dong Hwan Kim, MD, PhD8, Fotios V. Michelis9*, Armin Gerbitz10*, Jeffrey H. Lipton11, Rajat Kumar7, Jonas Mattsson11* and Auro Viswabandya, MD, DM12*

1Hans Messner Allogenic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada
2Hematopoietic Cell Transplant Unit, Hospital Clinic de Barcelona, Barcelona, Spain
3Allogeneic Hematopoietic Cell Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada
4Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
6Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada
7Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
8Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
9Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
10Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada
11Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
12Hans Messner Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

A Samer Al-Homsi1, Frank Cirrone1*, Kelli Cole1*, Jaime Andres Suarez-Londono1*, Sharon L. Gardner2*, Jingmei Hsu, MD, PhD1*, Stephanie Wo1*, Kelsey Stocker1*, Benedetto Bruno, MD, PhD3*, Judith Goldberg, ScD4*, Benjamin Levinson4* and Maher Abdul-Hay1*

1Blood and Marrow Transplantation and Cellular Therapy, New York University Langone Health, New York, NY
2Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, NYU Langone Health, New York, NY
3Division of Hematoloty, University of Torino, Torino, Italy
4Department of Biostatistics, NYU Grossman School of Medicine, New York, NY

María Laura Fox, MD1*, Alba Cabirta2*, Ariadna Pérez Martínez3*, Albert Esquirol, MD4,5*, Marta Fonseca6,7*, Víctor Navarro Garcés8*, Inmaculada Heras, MD, PhD9*, Leyre Bento, MD, PhD10*, Aida Calo Pérez11*, Teresa Zudaire, MD12*, Maria Calbacho, MD13*, Beatriz Gago14*, Ana Pérez, MD15*, Guillermo Ortí, MD, PhD16,17,18*, Irene García-Cadenas, MD19,20*, Lucía López Corral, MD21*, José Navarro-Fernández22*, Juan Montoro Gomez23*, Antonia Sampol, MD24, Carlos Solano, MD, PhD25,26 and David Valcarcel, MD, PhD27

1Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron., Barcelona, Spain, Barcelona, Spain
2Servei D'Hematologia, Vall D'Hebron Hospital Universitari,, Barcelona, Spain
3Hematology Department, Hospital Universitario Clínico de Valencia, Valencia, Spain
4Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
5Universitat Autònoma de Barcelona, Barcelona, Spain
6Hematology Department, Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), Salamanca, Spain
7Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
8Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), BARCELONA, Spain
9Hematology Department, Hospital Universitario Morales Meseguer, Murcia, Spain
10Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
11Hematology department, Hospital Clínico de San Carlos, Madrid, Spain
12Complejo Hospitalario de Navarra, Pamplona, Spain
13Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain, Spain
14Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain
15Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
16Department of Medicine. Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
17HU Vall d’Hebron, Barcelona, Spain
18Laboratory of Experimental Hematology, Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, BARCELONA, Spain
19Universidad Autónoma de Barcelona, Barcelona, Spain
20Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
21Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
22Hematology department, Hospital Morales Meseguer, MURCIA, Spain
23Hospital Universitario La Fe, Valencia, Spain
24Hematology and Hemotherapy Department, Son Espases University Hospital, IdISBa, Palma, Spain
25Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
26Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
27Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain

Di Yao, MM*, Jie Li, MD*, Bohan Li, MM*, Jun Lu, MD*, Jing Ling, MD*, Defei Zheng, MD*, Peifang Xiao, MD*, Lijun Meng, PhD*, Shaoyan Hu, MD, PhD and Yuanyuan Tian*

Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China

Zengkai Pan1*, Yujun Deng2*, Aijie Huang3*, Zilu Zhang1*, Luxiang Wang1*, Hongbo Hu2*, Jianmin Wang3 and Xiaoxia Hu1*

1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Department of Neurology and Center for Immunology and Hematology, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, China
3Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, China

Hany Elmariah, MD, MS1, Salman Otoukesh, MD2*, Ambuj Kumar, MD, MPH3*, Haris Ali, MD2, Shukaib Arslan, MD2*, Amrita Desai, MD2*, Amanda Blackmon, DO, MS2, Hoda Pourhassan, MD2*, Taiga Nishihori, MD4, Rawan Faramand, MD4, Asmita Mishra, MD4, Farhad Khimani, MD4, Hugo F Fernandez, MD5*, Aleksandr Lazaryan, MD, PhD, MPH4, Michael Nieder, MD1*, Lia Perez, MD1*, Hien D. Liu, MD1, Ryotaro Nakamura, MD2*, Joseph Pidala, MD, PhD4, Guido Marcucci, MD6, Stephen J Forman, MD2, Claudio Anasetti, MD4, Frederick L. Locke, MD4, Nelli Bejanyan, MD4 and Monzr M. Al Malki, MD2

1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Morsani College of Medicine, University of South Florida, Tampa, FL
4Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Pembroke Pines
6Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Thomas Luft, MD, PhD1, Salim Oulghazi2*, Caroline Pabst3*, Leonard Petry2*, Richard Huth2*, Carsten Müller-Tidow, MD1* and Peter Dreger, MD4*

1Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
2University Hospital Heidelberg, Heidelberg, Germany
3Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
4Department of Medicine V, University of Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany

Adam Kuba1*, Ludek Raida, MD, PhD2*, Patrik Flodr3*, Frantisek Mrazek4*, Eva Kriegova, Dr, assoc prof5*, Tomáš Papajík, MD, CSc, Prof6* and Jiri Minarik, MD6

1Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic, Olomouc, AL, Czech Republic
2Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
32. Department of Clinical and Molecular Pathology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic, Olomouc, Czech Republic
4Department of Immunology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic, Olomouc, Czech Republic
5Department of Immunology, Faculty Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
6Department of Hemato-oncology, Faculty Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic

Annalisa Paviglianiti, MD1,2*, Alberto Mussetti3,4*, Maud Ngoya5*, Ariane Boumendil, PhD6,7*, Zafer Gulbas8*, Fabio Ciceri, MD9*, Francesca Bonifazi, MD10*, Domenico Russo, MD11, Nathalie Fegueux, MD12*, Friedrich Stölzel13*, Claude-Eric Bulabois, MD14*, Gerard Socie, MD, PhD15, Edouard Forcade, MD, PhD16, Carlos Solano, MD, PhD17,18, Hervé Finel6*, Stephen Robinson, MD, PhD19*, Silvia Montoto, MD20,21 and Bertram Glass, MD7,22*

1Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, Barcelona, Spain
2Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain
3Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
4Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain
5Department of Hematology and Cell Therapy, EBMT Paris Study Office, Paris, France
6EBMT Lymphoma Working Party Paris Office, Paris, France
7Lymphoma Working Party, EBMT Central Registry Office, Paris, France
8Anadolu Medical Center Hospital, Bone Marrow Transplantation Department, Kocaeli, Turkey
9Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
10IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, NA, Italy
11Unit of Blood Diseases and Bone Marrow Transplantation, ASST Spedali Civili, University of Brescia, ASST Spedali Civili, Brescia, Italy
12Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
13University Hospital, TU Dresden,Germany, Dresden, Germany
14Service d'Hématologie, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
15Department of Hematology – BMT, Hopital St. Louis, Paris, France
16Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
17Department of Medicine, University of Valencia, Valencia, Spain
18Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
19University Hospital Bristol, Bristol, United Kingdom
20EBMT Lymphoma Working Party and St. Bartholomew´s Hospital, Barts Health NHS Trust, London, United Kingdom
21Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
22Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany

Scott R. Solomon, MD1, Lizamarie Bachier-Rodriguez, MD1*, Xu Zhang, PhD2*, H. Kent Holland, MD1, Lawrence E. Morris Jr., MD1*, Asad Bashey, MD, PhD1 and Melhem Solh, MD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2Center for Clinical and Transitional Sciences, University of Texas Health Science Center, Houston, TX

Rohtesh S. Mehta, MD1, Rima M. Saliba, PhD1*, Amin M Alousi, MD1, Gheath Alatrash, PhD, DO2, Qaiser Bashir, MD1, Chitra Hosing, MD1, Partow Kebriaei, MD1, Issa F. Khouri, MD1, Yago Nieto, MD3, Betul Oran, MD, MS4, Uday R Popat, MD1, Muzaffar H Qazilbash, MD1, Jeremy L. Ramdial, MD1, Gabriela Rondon, MD5, Samer A Srour, MD, MS6, Katy Rezvani, MD1, Richard E Champlin, MD1, Elizabeth J Shpall, MD1 and Kai Cao, MS, MD7

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Pearland, TX
3Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
4Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
7Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Ruihao Huang1*, Ting Chen1*, Sanbin Wang2*, Jishi Wang, PhD3, Yi Su, MD4*, Jing Liu, M.D., Ph.D.5*, Peiyan Kong6*, Cheng Zhang, MD, PhD7*, Lei Gao8*, Li Gao8* and Xi Zhang, MD, PhD1*

1Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
2920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, China
3Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang City, China
4General Hospital of Chengdu Military Region of People’s Literation Arm, Chengdu, China
5Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, China
6Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China, Chongqing, China
7Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, Chongqing, China
8Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, chongqing, China

Sharmila Raghunandan, DO, MPH1, Lev Gorfinkel, MD2, Michael Graiser, PhD3*, Brandi Bratrude, BA2*, Kayla Betz, BS, MPH4*, Yvonne Suessmuth, PhD1*, Scott Gillespie, MS5*, Adrianna Lynn Westbrook, MPH5*, Kirsten M. Williams, MD1, Michelle Schoettler, MD1*, Amelia Langston, MD6, Leslie Kean, MD, PhD7, Muna Qayed, MD, MSc8, John T. Horan, MD, MPH2 and Benjamin Watkins, MD1

1Emory University, Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
2Dana-Farber Cancer Institute, Boston Children’s Hospital, Boston, MA
3Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA
4Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston
5Pediatric Biostatics Core, Emory University, Atlanta, GA
6Emory University, Winship Cancer Institute, Atlanta, GA
7Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
8Emory University, Atlanta, GA

Everett H Meyer, MD, PhD1*, M Scott Killian, PhD2*, Anna Pavlova, MD, PhD3*, Cameron Bader3*, Sean Summers2*, Fernando Teque2*, J Scott McClellan, MD, PhD2 and Nathaniel B Fernhoff, PhD2*

1Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
2Orca Bio, Menlo Park, CA
3Stanford University, Stanford, CA

Hannah Choe, MD1, Nicholas Yuhasz, MS1*, Greer Elizabeth Miller1*, Me'kayla Travis2*, Avinash Karanth, PhD2*, Kyle Shifflet2* and Parvathi Ranganathan, PhD1

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2School of Electrical Engineering and Computer Science, Ohio University, Athens, OH

Valentin Letailleur1*, Amandine Le Bourgeois, PhD2*, Thierry Guillaume, MD, PhD2*, Pierre Peterlin, MD3*, Alice Garnier, MD4*, Maxime Jullien, MD5*, Marianne Coste-Burel, MD, PhD6*, Marie C Béné, PharmSciD, PhD7* and Patrice Chevallier, MD4

1Clinical Hematology Department, Nantes University Hospital, Angers, France
2Clinical Hematology Department, Nantes University Hospital, Nantes, France
3Clinical Hematology, Nantes University Hospital, Nantes, France
4Hematology Department, Nantes University Hospital, Nantes, France
5Clinical Hematology, Nantes University Hospital, NANTES, France
6Virology, Nantes University Hospital, Nantes, France
7Biology Department, Nantes University Hospital, Nantes, France

Alistair Murray1, Swe Mar Linn, MBBS2, Benoit Yu3*, Igor Novitzky-Basso, MD4, Jonas Mattsson4*, Mohamed Elemary, MD5*, Jennifer White, MD, MSc, FRCPC6*, Christopher Lemieux, MD7, Kareem Jamani, MD1* and Dennis Kim, MD, PhD4

1Division of Hematology and Hematologic Malignancies, University of Calgary, Calgary, AB, Canada
2Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada
3Laval University, Quebec, QC, Canada
4Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada
5University of Saskatchewan, Saskatoon, Canada
6The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
7Centre intégré de cancérologie, CHU de Québec - Université Laval, Quebec, QC, Canada

Omar Albanyan, MD1,2, Syeda Mahrukh Hussnain Naqvi, MD, MHS3*, Qianxing Mo, PhD3*, Athena Belfon4*, Eric Gaskill, PharmD2*, Taiga Nishihori, MD5, Rawan Faramand, MD2, Aleksandr Lazaryan, MD, PhD, MPH2, Doris K. Hansen, MD5, Farhad Khimani, MD2, Asmita Mishra, MD2, Michael Nieder, MD5*, Lia Perez, MD5*, Hien D. Liu, MD5, Joseph Pidala, MD, PhD2, Claudio Anasetti, MD2, Frederick L. Locke, MD2, Nelli Bejanyan, MD2 and Hany Elmariah, MD, MS5

1Adult Hematology- Oncology and SCT, King Fahad Specialist Hospital., Dammam, Saudi Arabia
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4H. Lee Moffitt Cancer Center & Research Institute, Tampa
5Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL

*signifies non-member of ASH